Andrew Cavey

Andrew Cavey serves as Chief Executive Officer at ITM Isotope Technologies Munich SE. ITM Isotope Technologies Munich SE operates in the pharmaceuticals sector with approximately 530.0 employees. The company is headquartered in Basel, Basel-Stadt. ITM Isotope Technologies Munich SE generates annual revenue of 15000000.0. To date, ITM Isotope Technologies Munich SE has raised 692083190.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 259 executive contacts are available in Basel-Stadt.
• • Our database includes 201,464 c suite-level executives.

Outlook TYPO3 Mobile Friendly Bootstrap Framework Apache SAP Qlik Sense

theranostic radioisotope platform technologies global network to guarantee security of supply strategic alliances in order to further develop theranostics driving force to establish global standards regarding safety & efficacy of radiopharmaceuticals pharmaceutical manufacturing radiopharmaceuticals clinical trials precision oncology radiolabeling gmp radiolabeling service medical radioisotopes therapeutic isotopes targeted radionuclide therapy dual-action treatments non-carrier added lutetium-177 actinium-225 endolucinbeta tocscan theranostics diagnostic radiopharmaceuticals improved patient outcomes neuroendocrine tumors glioblastoma treatment prostate cancer therapy ovarian cancer treatment supply agreements pipeline therapy expanded access programs quality control equipment biotech partnerships global supply network patient-centric approach adenocarcinoma n.c.a. 177lu labeling clinical diagnostics oncology research innovative treatments scientific publications therapeutic radioisotopes compliance in production preclinical studies clinical studies fda approvals cancer diagnostics pharmaceutical development radiopharmaceutical biomarkers collaboration agreements reagents for synthesis advanced cancer therapies multifaceted oncology solutions evidence-based treatments biotechnology cancer therapeutics radioisotopes lutetium-177 clinical development phase iii studies radiochemistry gmp radiolabeling radiation safety quality control patient care unmet medical needs global supply cancer treatment advanced diagnostics targeted therapies clinical outcomes patient quality of life oncology market vertical integration research & development collaboration precision medicine pharmaceuticals medical health care health wellness & fitness hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Andrew Cavey in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at ITM Isotope Technologies Munich SE.

Andrew Cavey's Position in the MessageCEO Database

• •Andrew Cavey is 1 of 1 verified executive contact we track at ITM Isotope Technologies Munich SE.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •255 verified executive contacts in Basel-Stadt are in the database.
• •12 verified contacts work at pharmaceuticals companies in the 530.0 employee range (same size as ITM Isotope Technologies Munich SE).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Andrew Cavey directly?

Andrew Cavey's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at ITM Isotope Technologies Munich SE. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Andrew Cavey work for?

Andrew Cavey is Chief Executive Officer at ITM Isotope Technologies Munich SE, a company in the pharmaceuticals sector with 530.0 employees. The company is based in Basel, Basel-Stadt.

Can I pitch or sell to Andrew Cavey?

As Chief Executive Officer at ITM Isotope Technologies Munich SE, Andrew Cavey is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Andrew Cavey directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Andrew Cavey in?

Andrew Cavey works in the pharmaceuticals industry as Chief Executive Officer at ITM Isotope Technologies Munich SE. MessageCEO provides verified contact information for executives across all major industries.

Is Andrew Cavey's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Andrew Cavey's profile is kept up-to-date with the latest available information.

Last updated: November 1, 2026